Skip to content

Prime Medicine PRME Operating Lease Liabilities

Operating Lease Liabilities at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.99B+29.2%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$61.4M-23.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$183.56M-9.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$135.85M-6.3%
Regenxbio logo
RegenxbioRGNX
$63.2M-12.1%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$198.51M-3.4%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's operating lease liabilities?
Prime Medicine (PRME) reported operating lease liabilities of $105.97M in Q1 2026.
How has Prime Medicine's operating lease liabilities changed year-over-year?
Prime Medicine's operating lease liabilities decreased by 7.3% year-over-year, from $114.29M to $105.97M.
What is the long-term trend for Prime Medicine's operating lease liabilities?
Over 4 years (2021 to 2025), Prime Medicine's operating lease liabilities has grown at a 143.7% compound annual growth rate (CAGR), from $3.07M to $108.29M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.